<4D6963726F736F667420576F7264202D20A655C3FEC4DDA9F3534B4CA448ADFBACECACE3B6B5A5D8B24DB3E6B8EAAEC62E646F63>Teng (Tripterygium Wilfordii Hook f) and their
nano-particle drug carrier for treating chronic
nephritis

017/2010/A2

GA frame-work for pattern discovery in
bioinformatics
059/2010/A3
neural networks
034/2011/A2
approach

039/2011/A2
LC-MSLC-NMR

lipidomic platform and its application in Chinese
medicine research
064/2011/A3
chemotherapy : comparison of the effects of
Tripterygium wilfordii with other selected herbal
extracts in cell models of resistant lung, pancreatic
and prostate cancers
065/2011/A3


and influence on the immune organs between
dexamethasone and flavanones derived from Chinese
medicinal herbs

Ting Li
066/2011/A3
Ginsenosides: identification of the oxygenated
metabolites and analysis of the responsible P450
isoforms

069/2011/A3
from Chinese medicinal herbs and evaluation of their
anti-inflammatory activities
071/2011/A3
(SNP)

nucleotide polymorphorism and bioactivities
073/2011/A3



research of cardiomyocyte mitochondrial dynamics
and mechanistic study of anti-ischemia heart disease
effects of protopanaxatriol-type Ginsenosides
074/2011/A3


molecular targets for treating Gefitinib-resistant
non-small cell lung cancer (NSCLC)

076/2011/A3


Chinese medicinal herbs as potential candidate agents
for the treatment of neurodegenerative conditions

013/2012/A1
Saikosaponin-d through the induction of autophagic
cell death
014/2012/A1


Sinomenine induced allergic dermatitis based on
integrated metabolomic approaches
040/2012/A



049/2012/A2


traditional Chinese medicine Huangqisan for
preventing diabetic nephropathy by cell membrane
chromatography
050/2012/A2


derivatives effect on hematopoietic and leukemic
stem cells
088/2012/A3
PCR

Neo-tanshinlactone against breast cancer and drug
screening based on the same mechanism

089/2012/A3
BMSCsMCAo

combined with BMSCs modulating angiogenesis in
ischemic boundary zone of MCAo model rats

090/2012/A3


non-alcoholic steatohepatitis

Ying Xie
091/2012/A3


efficacy enhancing in combination with nucleoside
analogues
092/2012/A3
standards for quality control of the pharmaceutical
preparations derived from Chinese herbal formula by
using polytechnic cutting-edge chemical and
biological technologies

Liang Liu
094/2012/A3


poorly water-soluble Flavonoids
007/2013/A
-

effects of muscone on myocardial ischemia -
reperfusion injury in rats
018/2013/A3
RORγtTh17

autoimmunity by ROR ligands derived from Chinese
medicinal compounds

Ting Li
019/2013/A1


active ingredients against influenza virus from Radix
Isatidis

020/2013/A1


bioactive components from Chinese medicines
targeting modulation of immunoglobulin g
glycosylation

021/2013/A1

from Chinese herbal medicine by modulating
metabolic profiles of cancer cells

052/2013/A2


ischemic preconditioning and effects of Piceatannol
and its dimers
055/2013/A2
inhibitors as autophagy regulators
056/2013/A2
Calotropis-1
plants and evaluation of their Hypoxia Inducible
Factor-1 (HIF-1) inhibitory activity
082/2013/A3
drug targeting ALK and ROS1 proteins by using
computational docking technology and bioassay

084/2013/A3


endoplasmic reticulum Ca 2+
cancer

086/2013/A3


Aconitum carmichaeli based on NMR and
hyphenated techniques

Na Li
087/2013/A3


treatment using multiple analytical approaches

089/2013/A3
--

microfluidic technology
090/2013/A3


components from Radix Polygalae (Yuan Zhi) for the
modulation of age-related neurodegenerative diseases

099/2013/A3



Yong Liang
014/2014/A1


nanostructure-based drug delivery system for
reducing toxicity and enhancing anticancer efficacy
of natural products
015/2014/A1
on the gut microflora and host intestinal mucosal
immune responses in the Apc min/+
colorectal cancer
therapy

028/2014/A1


esophageal cancer studied by bionanotechnology

035/2014/A1
function mechanism of Gua-Lou-Xie-Bai Bai-Jiu
decoction for the treatment of chest stuffiness and
pains

037/2014/A1


correlation for establishing novel quality control
method of new proprietary Chinese medicine
Guang-Xin-Kang-Tai
071/2014/A


butyricacid metabolism in the gut

077/2014/A2


of Rheumatoid arthritis
106/2014/A3
metabolic coupling after ischemic stroke based on
astrocytic vasoactive intestinal polypeptide receptors
(VPACs) for target
002/2015/A1


K + channels as biomarkers after the influence of
Chinese herbal extracts and therapeutic targets

006/2015/A1

impacts of tonic Chinese herbs on DNA damage and
repair
033/2015/A1
medicines to selectively up-regulate Bip expression
for neuroprotection
034/2015/A1

evaluation of anticancer effects
() / FDCT Projects (Pending):
species and redox balance in regulation of non-small
cell lung cancer
resistant prostate cancer - achieving improved
efficacy as well as product quality


Ying Xie
T-cell malignancies
neuroprotection based on the homeostasis of
neurotransmitters in vivo

The study of AMPK in the treatment effects of H2S
and its therapeutic potential against anemia of
inflammation

mechanism of Zhi-Kuo-Ning formula on airway
inflammation, airway remodeling in Bronchiectasis

004/2005/A

with Xiao-Liu tablets
006/2005/A

Ganoderma triterpenoids and its anti-cancer
properties

027/2005/A

Ruthenium complex with anti-cancer properties

028/2005/A

JTC
042/2005/A
C+C+D system construction

044/2005/A

nutriceutical

089/2005/A

effects with Bu-Shen-Zhuang-Gu capsules
105/2005/A


hypertension and protection of vascular endothelial
cells

018/2006/A


034/2006/A
ovariectomized rats with Epimedium Flavonoids

032/2006/A2

A research of medicine in health care for busy life
people
020/2007/A2

Chinese medicine Stauntonia chinensis
027/2007/A2

orally disintegrating tablets
039/2007/A3


Legionella in hospitals and public environment in
Macau

043/2007/A3
Chinese medicine against respiratory viral infections
immobilized by viral receptors on the membrane of
respiratory cells or immune cell

Quan Zhu
021/2008/A

complex optimization problems
048/2008/A3


marrow stromal cells(BMSCs)
after stroke
012/2009/A1

Ruthenium complex containing ingredient of
traditional Chinese medicine
016/2009/A1


Schwann cells basement membrane formed in vitro

039/2009/A


Interferon activity gene and its application for
isolation of influenza virus
091/2009/A
on lung tumor cell’s sensitivity to TRAIL- induced
apoptosis and the related mechanism

071/2009/A3
application

003/2011/A

delivery systems of scutellarin
035/2011/A2

action targets of Rh2E2, a new derivative of
ginsenoside, on anti-cancer by using proteomics
technology
051/2012/A

delivery systems of Berberine
093/2012/A

induced by Toosendanin
() /
Ministry of Science and Technology of PRC and FDCT Joint Research
Funding Projects (In Progress):
Project No.
therapy resistance for network-based drug discovery
with Chinese herbal medicine
() /
Ministry of Science and Technology of PRC and FDCT Joint Research
Funding Projects (Pending):

moxibustion prescription for Analogous Syndromes
in Shang-Han-Lun based on the formula-syndrome
pathogenesis

melanogenesis induced by
of glucosaminosides of Shikonin and Alkannin

MALDI-TOF-MS techniques
ginseng
glabra using combined LC, MS and NMR

in three Polygonum species
medicinal herbs for treating Gefitinib-resistant
non-small cell lung cancer (NSCLC)

fluorescence analysis in hypoxia cardiomyocyte
mitochondrial dynamic

Pei Luo
treatment of neurodegenerative conditions
inhibition of IKKb-IkBa-NF-kB and MAPK
signaling pathway

Ting Li
different parts of Notoginseng root

effect from an alkaloid type compounds and study of
its preliminary action mechanisms
on haematopoietic stem cell function


Tao Yi
medicines

Silymarin
Huangqin decoction

Wei Zhang
neurodegeneration in palmitic acid-treated SHSY5Y
neuronal cells
from Chinese herbal medicine by modulating
metabolic profiles of cancer cells

herbal medicine from Macau
hydrophobic anticancer drug delivery

syndrome quantitative diagnosis in psychological
sub health
in Macao